Literature DB >> 34741749

Relation of Carotid Plaque Features Detected with Ultrasonography-Based Radiomics to Clinical Symptoms.

Zhe Huang1, Xue-Qing Cheng1, Hong-Yun Liu1, Xiao-Jun Bi1, Ya-Ni Liu1, Wen-Zhi Lv2, Li Xiong3, You-Bin Deng4.   

Abstract

Carotid plaque is one of the predominant causes of stroke. We sought to build a nomogram using ultrasonography (US)-based radiomics and clinical features for identification of symptomatic carotid plaques. We prospectively enrolled 548 patients (mean age ± standard deviation, 63 ± 10 years; 373 men) were randomly divided into training and test cohorts. Clinical and conventional US features of carotid plaques were used to generate a clinical and conventional US model. US-based radiomics model was constructed by extracting radiomics features from grayscale and strain elasticity images. Multivariate logistic regression was performed using the radiomics scores together with clinical and conventional US data, and a final nomogram was subsequently developed. The performance of the final nomogram was assessed with respect to discrimination and clinical usefulness in the training of the test cohorts and contrast-enhanced US test cohort. All the radiomics scores were significantly higher in patients with symptomatic carotid plaques. The US-based radiomics model [area under the curve (AUC) = 0.930 and 0.922 for training and test cohorts, respectively] and final nomogram (AUC = 0.927 and 0.919, respectively) outperformed the clinical and conventional US model (AUC = 0.723 and 0.580, respectively). The decision curve analysis indicated that the final nomogram was clinically useful. In patients undergoing the contrast-enhanced US, the prevalence of plaque enhancement was higher in high-risk patients than in low-risk patients based on the final nomogram-score (P = 0.008). Nomogram has a high diagnostic performance for identification of symptomatic carotid plaques.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Carotid plaques; Nomogram; Ultrasonography-based radiomics

Year:  2021        PMID: 34741749     DOI: 10.1007/s12975-021-00963-9

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.800


  26 in total

Review 1.  Ultrasound Characteristics of Symptomatic Carotid Plaques: A Systematic Review and Meta-Analysis.

Authors:  Waleed Brinjikji; Alejandro A Rabinstein; Giuseppe Lanzino; Mohammad H Murad; Eric E Williamson; J Kevin DeMarco; John Huston
Journal:  Cerebrovasc Dis       Date:  2015-08-13       Impact factor: 2.762

2.  Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study.

Authors:  J N E Redgrave; J K Lovett; P J Gallagher; P M Rothwell
Journal:  Circulation       Date:  2006-05-01       Impact factor: 29.690

3.  The utility of ultrasonic tissue characterization of carotid plaque in the prediction of cardiovascular events in diabetic patients.

Authors:  Yoko Irie; Naoto Katakami; Hideaki Kaneto; Mitsuyoshi Takahara; Mayu Nishio; Ryuichi Kasami; Ken'ya Sakamoto; Yutaka Umayahara; Satoru Sumitsuji; Yasunori Ueda; Keisuke Kosugi; Iichiro Shimomura
Journal:  Atherosclerosis       Date:  2013-08-26       Impact factor: 5.162

4.  High-resolution magnetic resonance imaging of carotid atherosclerosis identifies vulnerable carotid plaques.

Authors:  Antoine Millon; Jean-Louis Mathevet; Loic Boussel; Peter L Faries; Zahi A Fayad; Philippe C Douek; Patrick Feugier
Journal:  J Vasc Surg       Date:  2013-02-01       Impact factor: 4.268

5.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).

Authors:  Victor Aboyans; Jean-Baptiste Ricco; Marie-Louise E L Bartelink; Martin Björck; Marianne Brodmann; Tina Cohnert; Jean-Philippe Collet; Martin Czerny; Marco De Carlo; Sebastian Debus; Christine Espinola-Klein; Thomas Kahan; Serge Kownator; Lucia Mazzolai; A Ross Naylor; Marco Roffi; Joachim Röther; Muriel Sprynger; Michal Tendera; Gunnar Tepe; Maarit Venermo; Charalambos Vlachopoulos; Ileana Desormais
Journal:  Eur Heart J       Date:  2018-03-01       Impact factor: 29.983

6.  Utility of the assessment of echogenicity in the identification of symptomatic carotid artery atheroma plaques in ischemic stroke patients.

Authors:  G Ruiz-Ares; B Fuentes; P Martínez-Sánchez; M Martínez-Martínez; E Díez-Tejedor
Journal:  Cerebrovasc Dis       Date:  2011-11-18       Impact factor: 2.762

Review 7.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

8.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.

Authors:  H J Barnett; D W Taylor; M Eliasziw; A J Fox; G G Ferguson; R B Haynes; R N Rankin; G P Clagett; V C Hachinski; D L Sackett; K E Thorpe; H E Meldrum; J D Spence
Journal:  N Engl J Med       Date:  1998-11-12       Impact factor: 91.245

9.  High-Intensity Signal in Carotid Plaque on Routine 3D-TOF-MRA Is a Risk Factor of Ischemic Stroke.

Authors:  Kiyofumi Yamada; Masanori Kawasaki; Shinichi Yoshimura; Manabu Shirakawa; Kazutaka Uchida; Seigo Shindo; Shuji Nishida; Yasuhiro Iwamoto; Shigehiro Nakahara; Yoshikazu Sato
Journal:  Cerebrovasc Dis       Date:  2015-11-19       Impact factor: 2.762

10.  Comparison of symptomatic and asymptomatic atherosclerotic carotid plaques using parallel imaging and 3 T black-blood in vivo CMR.

Authors:  Jochen M Grimm; Andreas Schindler; Tobias Freilinger; Clemens C Cyran; Fabian Bamberg; Chun Yuan; Maximilian F Reiser; Martin Dichgans; Caroline Freilinger; Konstantin Nikolaou; Tobias Saam
Journal:  J Cardiovasc Magn Reson       Date:  2013-05-24       Impact factor: 5.364

View more
  3 in total

1.  Letter to Relation of Carotid Plaque Features Detected with Ultrasonography‑Based Radiomics to Clinical Symptoms.

Authors:  Bin Zhang
Journal:  Transl Stroke Res       Date:  2022-01-14       Impact factor: 6.800

2.  Prediction of Carotid In-Stent Restenosis by Computed Tomography Angiography Carotid Plaque-Based Radiomics.

Authors:  Xiaoqing Cheng; Zheng Dong; Jia Liu; Hongxia Li; Changsheng Zhou; Fandong Zhang; Churan Wang; Zhiqiang Zhang; Guangming Lu
Journal:  J Clin Med       Date:  2022-06-06       Impact factor: 4.964

3.  A Radiomics Approach to Assess High Risk Carotid Plaques: A Non-invasive Imaging Biomarker, Retrospective Study.

Authors:  Sihan Chen; Changsheng Liu; Xixiang Chen; Weiyin Vivian Liu; Ling Ma; Yunfei Zha
Journal:  Front Neurol       Date:  2022-03-08       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.